Jay Olson
Stock Analyst at Oppenheimer
(4.42)
# 349
Out of 5,182 analysts
253
Total ratings
45.93%
Success rate
24.68%
Average return
Main Sectors:
Stocks Rated by Jay Olson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TERN Terns Pharmaceuticals | Downgrades: Perform | n/a | $52.96 | - | 5 | Apr 27, 2026 | |
| PASG Passage Bio | Maintains: Outperform | $30 → $15 | $5.78 | +159.52% | 2 | Apr 21, 2026 | |
| RVMD Revolution Medicines | Maintains: Outperform | $150 → $165 | $143.00 | +15.38% | 11 | Apr 13, 2026 | |
| BIIB Biogen | Maintains: Outperform | $250 → $275 | $182.48 | +50.70% | 27 | Apr 1, 2026 | |
| BCYC Bicycle Therapeutics | Maintains: Outperform | $44 → $36 | $4.77 | +654.72% | 5 | Mar 18, 2026 | |
| VRTX Vertex Pharmaceuticals | Maintains: Outperform | $540 → $600 | $427.47 | +40.36% | 2 | Mar 10, 2026 | |
| BIOA BioAge Labs | Initiates: Outperform | $60 | $18.16 | +230.40% | 1 | Feb 25, 2026 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Perform | $21 → $23 | $22.50 | +2.22% | 16 | Feb 6, 2026 | |
| CHRS Coherus Oncology | Initiates: Outperform | $10 | $1.85 | +440.54% | 1 | Jan 22, 2026 | |
| PRAX Praxis Precision Medicines | Maintains: Outperform | $250 → $750 | $331.43 | +126.29% | 3 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $600 → $650 | $519.58 | +25.10% | 12 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $1.69 | +195.86% | 1 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $84 → $90 | $72.58 | +24.00% | 4 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $21 → $30 | $5.80 | +417.24% | 3 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $14 | $4.44 | +215.32% | 1 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $11.12 | - | 15 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $65 | $3.06 | +2,024.18% | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $65 | $0.94 | +6,816.00% | 5 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $13 | $1.17 | +1,015.88% | 3 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $90 | $86.80 | +3.69% | 6 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $50 → $42 | $20.34 | +106.49% | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | $41 → $33 | $45.36 | -27.25% | 6 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $40 | $13.49 | +196.52% | 9 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $20 | $5.62 | +255.87% | 2 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $30 | $8.62 | +248.03% | 1 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $81 → $82 | $96.78 | -15.27% | 14 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $138 | $33.77 | +308.65% | 8 | Sep 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $8 | $1.94 | +312.37% | 1 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $380 | $342.67 | +10.89% | 23 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $216 → $219 | $129.40 | +69.25% | 15 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Perform | $12 | $2.93 | +309.56% | 6 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 | $3.80 | +373.68% | 5 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 | $34.50 | +189.86% | 5 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $102 → $95 | $50.56 | +87.90% | 6 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $25 | $1.01 | +2,375.25% | 1 | Apr 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $9 | $1.25 | +620.00% | 4 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $1,200 → $500 | $1.60 | +31,150.00% | 4 | Nov 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Perform | $25 → $21 | $13.35 | +57.30% | 9 | Nov 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $7.11 | - | 2 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $84 | $16.52 | +408.36% | 1 | Mar 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $2.07 | - | 3 | Jul 11, 2017 |
Terns Pharmaceuticals
Apr 27, 2026
Downgrades: Perform
Price Target: n/a
Current: $52.96
Upside: -
Passage Bio
Apr 21, 2026
Maintains: Outperform
Price Target: $30 → $15
Current: $5.78
Upside: +159.52%
Revolution Medicines
Apr 13, 2026
Maintains: Outperform
Price Target: $150 → $165
Current: $143.00
Upside: +15.38%
Biogen
Apr 1, 2026
Maintains: Outperform
Price Target: $250 → $275
Current: $182.48
Upside: +50.70%
Bicycle Therapeutics
Mar 18, 2026
Maintains: Outperform
Price Target: $44 → $36
Current: $4.77
Upside: +654.72%
Vertex Pharmaceuticals
Mar 10, 2026
Maintains: Outperform
Price Target: $540 → $600
Current: $427.47
Upside: +40.36%
BioAge Labs
Feb 25, 2026
Initiates: Outperform
Price Target: $60
Current: $18.16
Upside: +230.40%
ACADIA Pharmaceuticals
Feb 6, 2026
Maintains: Perform
Price Target: $21 → $23
Current: $22.50
Upside: +2.22%
Coherus Oncology
Jan 22, 2026
Initiates: Outperform
Price Target: $10
Current: $1.85
Upside: +440.54%
Praxis Precision Medicines
Dec 15, 2025
Maintains: Outperform
Price Target: $250 → $750
Current: $331.43
Upside: +126.29%
Nov 20, 2025
Maintains: Outperform
Price Target: $600 → $650
Current: $519.58
Upside: +25.10%
Oct 21, 2025
Initiates: Outperform
Price Target: $5
Current: $1.69
Upside: +195.86%
Oct 8, 2025
Maintains: Outperform
Price Target: $84 → $90
Current: $72.58
Upside: +24.00%
Sep 25, 2025
Maintains: Outperform
Price Target: $21 → $30
Current: $5.80
Upside: +417.24%
Jul 29, 2025
Initiates: Outperform
Price Target: $14
Current: $4.44
Upside: +215.32%
May 27, 2025
Downgrades: Perform
Price Target: n/a
Current: $11.12
Upside: -
May 21, 2025
Initiates: Outperform
Price Target: $65
Current: $3.06
Upside: +2,024.18%
May 15, 2025
Maintains: Outperform
Price Target: $80 → $65
Current: $0.94
Upside: +6,816.00%
May 14, 2025
Maintains: Outperform
Price Target: $15 → $13
Current: $1.17
Upside: +1,015.88%
Mar 14, 2025
Upgrades: Outperform
Price Target: $90
Current: $86.80
Upside: +3.69%
Mar 3, 2025
Maintains: Outperform
Price Target: $50 → $42
Current: $20.34
Upside: +106.49%
Jan 24, 2025
Downgrades: Perform
Price Target: $41 → $33
Current: $45.36
Upside: -27.25%
Jan 13, 2025
Maintains: Outperform
Price Target: $60 → $40
Current: $13.49
Upside: +196.52%
Dec 11, 2024
Maintains: Outperform
Price Target: $80 → $20
Current: $5.62
Upside: +255.87%
Dec 6, 2024
Initiates: Outperform
Price Target: $30
Current: $8.62
Upside: +248.03%
Oct 30, 2024
Maintains: Outperform
Price Target: $81 → $82
Current: $96.78
Upside: -15.27%
Sep 25, 2024
Reiterates: Outperform
Price Target: $138
Current: $33.77
Upside: +308.65%
Aug 14, 2024
Assumes: Outperform
Price Target: $8
Current: $1.94
Upside: +312.37%
Aug 7, 2024
Maintains: Outperform
Price Target: $380
Current: $342.67
Upside: +10.89%
Aug 2, 2024
Maintains: Outperform
Price Target: $216 → $219
Current: $129.40
Upside: +69.25%
Jun 18, 2024
Maintains: Perform
Price Target: $12
Current: $2.93
Upside: +309.56%
May 15, 2024
Maintains: Outperform
Price Target: $18
Current: $3.80
Upside: +373.68%
May 15, 2024
Maintains: Outperform
Price Target: $100
Current: $34.50
Upside: +189.86%
May 10, 2024
Maintains: Outperform
Price Target: $102 → $95
Current: $50.56
Upside: +87.90%
Apr 12, 2024
Initiates: Outperform
Price Target: $25
Current: $1.01
Upside: +2,375.25%
Mar 27, 2024
Maintains: Outperform
Price Target: $9
Current: $1.25
Upside: +620.00%
Nov 30, 2023
Maintains: Outperform
Price Target: $1,200 → $500
Current: $1.60
Upside: +31,150.00%
Nov 22, 2023
Maintains: Perform
Price Target: $25 → $21
Current: $13.35
Upside: +57.30%
Oct 13, 2022
Downgrades: Perform
Price Target: n/a
Current: $7.11
Upside: -
Mar 20, 2018
Maintains: Outperform
Price Target: $70 → $84
Current: $16.52
Upside: +408.36%
Jul 11, 2017
Upgrades: Outperform
Price Target: n/a
Current: $2.07
Upside: -